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Abstract  
 
Background: The importance of exercise in the management of people with CF is well 
recognised, yet the effect of exercise on lung function is not well understood. FEV1 is 
insensitive to the detection of small changes in lung function. Ventilation MRI and LCI 
are both more sensitive to mild lung disease than FEV1 and may be better suited to 
assess the effects of exercise. Here we assessed the short-term effects of maximal 
exercise on the distribution of ventilation using ventilation MRI and LCI. 
Methods: Patients with CF and a range of lung disease were assessed. Baseline LCI and 
ventilation MRI was followed by a maximal cardio-pulmonary exercise test (CPET). 
Repeated ventilation MRI was performed within 30 minutes of exercise termination, 
followed by LCI and finally by FEV1.  
Results: 13 patients were recruited and completed all assessments. Mean (SD) age was 
25 (10) years and mean (SD) FEV1 z-score was -1.8 (1.7).  Mean LCI at baseline was 8.2, 
mean ventilation defect percentage on MRI (VDP) was 7.3%. All patients performed 
maximal CPET. Post-exercise, there was a visible change in lung ventilation in 85% of 
patients, including two patients with increased ventilation heterogeneity post-CPET 
who had normal FEV1. VDP and LCI were significantly reduced post-exercise (p<0.05) 
and 45% of patients had a significant change in VDP.  
Conclusions: Acute maximal exercise directly affects the distribution of ventilation on 
ventilation MRI in patients with CF. This suggests that exercise is beneficial in CF and 




129Xe – Xenon-129 
3He – Helium-3 
LCI – Lung Clearance Index 
MBW – Multiple Breath Washout 
VDP – Ventilation Defect Percentage 




Exercise is increasingly recognised as an important component of disease management 
in cystic fibrosis (CF)(1). Aerobic capacity, in particular the amount of oxygen uptake 
during maximal exercise (VO2peak), is highly predictive of long-term morbidity and 
mortality(2-4). VO2peak and other metrics calculated from lab-based cardio-pulmonary 
exercise testing (CPET) such as the ventilatory equivalents for O2 and CO2 (Ve/VO2 and 
Ve/VCO2 respectively), are strong predictors of hospitalisation(5), death and lung 
transplantation(4). As a result, there is increasing emphasis on performing routine lab-
based CPET assessments in CF because of the detailed physiological profiling the 
interpretation can provide(6).  
 
There is also recognition in the value of exercise as a form of chest physiotherapy(7). 
The increased minute ventilation associated with exercise, as well as the upper body 
movement that often accompanies exercise, causes increases in positive pressure within 
the lungs, which aids the clearance of mucus from airways(7). Many patients with CF use 
exercise as a primary form of physiotherapy(1) and the role of exercise in airway 
clearance has been highlighted as one of the most important questions that people with 
CF are interested in(8). Previous studies have demonstrated that maximal exercise 
causes an improvement in the lung clearance index (LCI)(9) measured during a multiple 
breath washout (MBW) test, suggesting ventilation heterogeneity is improved as a result 
of exercise. In contrast however, attempts at measuring long-term improvements in lung 
function due to regular exercise have not demonstrated significant changes in FEV1(10). 
FEV1 however is not a sensitive enough metric to monitor the effects of chest 
physiotherapy in general(11).  
 
Hyperpolarised gas ventilation MRI using helium-3 (3He) or, increasingly, xenon-129 
(129Xe) provides a direct visualisation in 3D of the distribution of ventilation within the 
lung. Ventilation MRI has been shown to be highly sensitive to early lung disease in 
CF(12) and to longitudinal disease progression(13). Ventilation MRI has also been 
shown to be effective at measuring the effect of interventions, including CTFR 
modulators(14) and antibiotics in response to acute exacerbation(15). A major strength 
of ventilation MRI, is the ability to quantitatively assess global and regional lung 
disease(16), with the ventilation defect percentage (VDP) being the most common 
metric reported. Previous studies have assessed the effect of chest physiotherapy using 
3He MRI, and shown that physiotherapy causes a re-distribution of ventilation that can 
be imaged and quantified(17-19). In addition to the detection of changes in regional 
ventilation, due to shifting mucus distribution, it might also be anticipated that the 
severity of ventilation abnormalities observed on MRI would be related to the degree of 
exercise impairment in people with CF. Ventilation MRI is thus a well-placed tool to 
assess both the impact of airway disease on exercise capacity, and the impact of exercise 
on lung physiology.  
 
In this work we hypothesised that a period of maximal exercise would result in airway 
clearance of obstructing secretions and hence in improvements in ventilation. We also 
hypothesised that exercise capacity would correlate with severity of lung disease as 
measured by ventilation heterogeneity on MRI.  
 
The aims of this study were therefore to;  
i) Assess the effects of maximal exercise on ventilation MRI and MBW.  






1.2.1 Study design 
This study forms part of a larger longitudinal study of LCI and MRI in children and adults 
with CF(16). In this interventional sub-study, patients performed MBW and imaging 
before and after a maximal CPET at one of their follow-up visits. Children and adults 
with CF were recruited from three specialist CF centres in the UK into the larger 
longitudinal study. Patients were eligible for this exercise sub-study if they were aged 
>10 years and if FEV1 >30% and were not pre-selected. Patients were screened against 
the recommended CPET contraindications(20) and in addition patients with 
Mycobacterium abscessus or Burkholderia cepacia were excluded from the larger study, 
as were patients with a pulmonary exacerbation within the previous four weeks. In total 
13 patients met the criteria and were assessed in this sub-study. The main limitation on 
participating in this sub-study were time constraints and the resulting potential patient 
fatigue after completing the rest of the protocol required for the longitudinal study. This 
study was approved by the Yorkshire and Humber - Leeds West Research Ethics 
Committee (REC reference: 16/YH/0339). All adult patients or parents of children 
provided written consent, children also provided written assent. Assessments took place 
between January 2017 and March 2019.  
 
1.2.2 Assessment protocol 
129Xe or 3He MRI were performed on a 1.5T GE HDX MRI scanner (GE, Milwaukee, USA). 
Images were acquired at a lung volume of end-inspiratory tidal volume as previously 
described, using titrated inhaled volumes of test gas(16). A 1H anatomical MRI was 
performed immediately prior to and at the same lung volume as the 129Xe image. 1H MRI 
was always re-acquired each time a 129Xe image was performed and was used to 
calculate the thoracic cavity volume at which images were acquired. 129Xe or 3He and 1H 
MRI were segmented using a semi-automated Fuzzy C-means clustering method, as 
previously described (21), in order to calculate VDP and the ventilation heterogeneity 
index (VHI)(16). More details on MRI sequences and gas doses can be found in the online 
supplement. 
 
MBW was performed on an open-circuit Innocor (Pulmotrace, Glamsberg, Denmark) 
using 0.2% SF6 as previously described(16, 22). Spirometry and body plethysmography 
were performed according to international recommendations(23, 24) on a ‘PFT Pro’ 
(Vyaire, Basingstoke, UK).  CPET was performed as recommended using a cycle 
ergometer and an ‘Ultima’ metabolic cart (Medical Graphics, Gloucester, UK)(6).  
 
The first two patients to perform the exercise assessment were assessed with 3He for 
ventilation MRI, and the remaining patients were assessed with 129Xe, for reasons of gas 
availability and a switch to 129Xe at our research centre. All patients performed the 
assessments in the same order. Ventilation MRI was performed first as a baseline 
measurement. This was followed by MBW and body plethysmography. A maximal CPET 
was then performed, followed by a repeat ventilation MRI within 30 minutes of the end 
of exercise. The repeat MBW was completed after this and spirometry was then 
performed at the end of the study visit. This sequence was the same for the two patients 
who were imaged with 3He. 
 
1.2.3 Analysis 
The primary metrics used for analysis were VDP from MRI, LCI from MBW, VO2peak 
from CPET, the residual volume to total lung capacity ratio (RV/TLC) from body 
plethysmography and FEV1 from spirometry. Secondary outcomes include: VHI from 
129Xe MRI, VO2AT (anaerobic threshold), Ve/VO2 and Ve/VCO2 at peak exercise from 
CPET and Scond (convection-dependent ventilation heterogeneity) and Sacin (convection-
diffusion dependent ventilation heterogeneity) from MBW. Prior to analysis, data were 
assessed for normal distribution using the Shapiro-Wilks text. An absolute change in 
VDP of >1.6% was used as the threshold above which a significant post-exercise 
response was determined, which represents the same-day repeatability of 129Xe VDP in 
CF patients(25),. The two subjects who were assessed with 3He were removed from this 
analysis. Wilcoxon signed rank test was performed to compare the initial baseline values 
with the post-exercise values from MRI and MBW. 3He and 129Xe VDP values were pooled 
for quantitative analysis; previously we have shown that there is good agreement  and 
minimal bias between the two gases in CF(26). Spearman’s correlation was performed 
to compare exercise outcomes to ventilation MRI and lung function. A p-value of 0.05 




Thirteen patients (including five patients under the age of 18 years), of whom five were 
female, completed the exercise study protocol. Patient demographics, and baseline lung 
function, MRI and CPET metrics are detailed in Table 1. Patients were aged between 
10.2 and 43.7 years (mean age = 25.2 years) and had a spread of FEV1 z-score values 
ranging from -4.4 to 0.92 (mean FEV1 z-score = -1.8). Six patients had an FEV1 within the 
normal range and five had a normal LCI (all of whom also had normal FEV1). All patients 
achieved a maximal effort on CPET, as defined by achieving a respiratory exchange ratio 
(RER) >1.05(6). 
Table 1: Baseline lung function, CPET and MRI metrics for the study population. Metrics are displayed for each individual patient within the study. Also 
documented are clinical demographics relating to the underlying CF and any previous diagnosis of asthma. Patient ^ indicates patients under the age of 
18 years. FEV1 – forced expiratory volume in one second. RV/TLC – the ratio of residual volume to total lung capacity. LCI – lung clearance index. Scond – 
convection-dependent ventilation heterogeneity. Sacin – convection-diffusion-dependent ventilation heterogeneity. VDP – ventilation defect percentage. 
VHI – ventilation heterogeneity index. VO2peak – oxygen uptake at peak exercise. VO2AT – oxygen uptake at the anaerobic threshold. Ve/VO2 – the ratio 
of minute ventilation to oxygen uptake or the ventilatory equivalent for oxygen. Ve/VCO2 – the ratio of minute ventilation to carbon dioxide production 
or the ventilatory equivalent for CO2. Clinical data relates to the date of testing and was recorded from the patient notes. Pseudomonas refers to whether 




























1 -4.2 48.7 14.0 0.07 0.37 45.2 19.1 29.4 12.6 43.8 36.0 DF508/DF508 Y N Y N 
2 -0.5 29.0 7.4 0.09 0.08 1.5 10.0 30.7 12.2 59.1 42.0 DF508/DF508 N N N N 
3 -3.3 41.4 11.4 0.12 0.26 20.8* 19.0* 40.5 15.7 35.5 30.0 DF508/DF508 N N Y N 
4^ 0.7 26.5 6.6 0.03 0.10 2.1* 9.4* 40.7 19.6 36.0 37.0 DF508/DF508 N N N N 
5 -2.7 34.4 9.4 0.14 0.22 17.8 12.3 38.1 18.9 39.0 31.0 R334W/R75X N N N N 
6^ -0.9 24.0 7.3 0.11 0.06 2.0 9.0 31.6 15.1 52.9 48.0 DF508/DF508 N Y Y N 
7^ 0.9 17.8 7.3 0.06 0.08 3.7 9.6 57.9 22.6 37.8 37.0 DF508/DF508 N N N N 
8 -2.4 31.0 8.2 0.07 0.23 7.3 15.4 37.4 18.7 46.0 33.0 DF508/DF508 Y N Y N 
9^ -0.5 22.0 7.6 0.11 0.09 2.7 9.5 49.1 19.1 48.9 37.0 DF508/Q493x N N Y N 
10 -2.8 51.9 14.6 0.12 0.16 20.2 18.7 37.8 15.4 30.1 26.0 DF508/R553X Y N N N 
11 -4.4 57.6 17.4 0.10 0.34 45.6 18.7 27.5 14.1 40.0 35.0 DF508/DF508 Y N Y Orkambi 
12^ -1.0 26.6 6.6 0.08 0.11 2.5 10.8 40.1 19.6 43.9 37.0 G551D/DF508 Y N Y Ivacaftor 
13 -2.8 45.3 13.0 0.15 0.14 30.8 19.5 33.8 14.3 42.5 34.0 DF508/W1282x Y N Y N 
1.3.1  129Xe ventilation MRI: Baseline  
 
At baseline, ventilation MRI defects were present in all patients. There was a wide range 
of disease severity with VDP ranging from 1.5 to 45.7%.  
 
1.3.2 Ventilation MRI and MBW: Baseline and Post-CPET comparison 
 
All patients successfully performed MRI and MBW post-CPET. There was a small but 
significant reduction in both VDP (p=0.04) and LCI (p=0.05) post-CPET when compared 
to baseline, but no significant change in VHI, Scond or Sacin (Table 2). The median 
difference (95% confidence intervals) for VDP showed a reduction of 1.5% (-0.4 to 
3.0%) and for LCI a reduction of 0.4 units (-0.2 to 1.1) was observed. When the two 
patients who performed 3He were removed from the VDP analysis, the p-value changed 
to 0.15 and the median difference to 0.9% (-1.4 to 3.7%). 
 
Table 2: Pre versus post CPET metrics for MRI and MBW for the whole group of patients. 
Data are displayed as either mean (SD) or median [IQR]. Statistically significant (p<0.05) 
changes in LCI and VDP post exercise as indicated by *.  
 Baseline Post-CPET 
LCI 8.2 [7.3, 13.5] 7.8 [7.0, 12.0]* 
Scond 0.10 (0.03) 0.09 (0.04) 
Sacin 0.17 (0.1) 0.18 (0.11) 
VDP (%) 7.3 [2.3, 25.8] 7.1 [2.4, 24.8]* 
VHI (%) 12.3 [9.6, 19.0] 11.4 [9.8, 16.8] 
 
 
Of the patients who performed the pre versus post exercise assessment with 129Xe MRI, 
5/11 patients had a change in VDP of >±1.6%. Of these five, four had a significant 
improvement in ventilation distribution and one had a significant worsening in the 
ventilation distribution (see Figure 1 for examples).  
 
 
Figure 1: Representative 129Xe ventilation image slices from six patients (a-f) at baseline 
and post-CPET. Two slice locations are shown per patient for comparison, depicting the change 
in ventilation that has occurred post-CPET. White dashed arrows in the post-CPET images 
highlight some of the areas of change in ventilation. Patients’ a-d had an overall improvement in 
ventilation post-CPET, whilst patients’ e and f had a worsening in ventilation post-CPET. 
Patient a) had a reduction in absolute VDP of -3.7% (baseline to post-CPET VDP = 45.7 to 41.9%). 
Patient b) had a reduction in absolute VDP of -3.0% (baseline to post-CPET VDP = 45.2 to 42.2%). 
Patient c) had a reduction in absolute VDP of -5.9% (baseline to post-CPET VDP = 17.8 to 11.9%). 
Patient d) had a reduction in absolute VDP of -1.9% (baseline to post-CPET VDP = 3.7 to 1.8%). 
Patient e) had an increase in absolute VDP of 1.4% (baseline to post-CPET VDP = 2.0 to 3.4%). 
Patient f) had an increase in absolute VDP of 1.6% (baseline to post-CPET VDP = 1.5 to 3.1%). For 
both patients’ e and f, the major areas of worsening ventilation post-CPET, appear to be in areas 
where ventilation defects were already present at baseline. 
 
Of the remaining six patients assessed with 129Xe MRI with a change in VDP of <±1.6%, 
only two had no clear visual change in the distribution of ventilation. The remaining 
patients with total VDP change <±1.6% all had visible changes in ventilation. One of 
these had a visual worsening in overall ventilation (patient e, Figure 1) and the 
remaining three had an approximately equal combination of areas of improved and 
decreased ventilation, with net change in VDP being small. The value of regional 
quantitative analysis is highlighted in Figure 1 (patient f), where the global change in 
VDP for this patient was 1.6%, however the change in the size of the defect evident in 
the right lung was 2.4%. The two patients assessed with 3He also had a visible 
improvement in areas of ventilation abnormalities and had overall reductions in 
absolute VDP of -2.3% and -1.6%. 
 
1.3.3 CPET metric comparisons with ventilation MRI and lung function 
 
VO2peak demonstrated significant correlations with RV/TLC (r=-0.64, p=0.02) and FEV1 
(r=0.57, p=0.047), whilst VO2AT demonstrated correlations with RV/TLC (r=-0.64, 
p=0.02) and LCI (r=-0.63, p=0.02). Peak exercise Ve/VO2 did not correlate with any 
imaging or lung function metrics. In contrast, peak exercise Ve/VCO2 demonstrated 
significant correlations with VDP (r=-0.72, p=0.007), RV/TLC (r=-0.70, p=0.01), LCI (r=-
0.69, p=0.01) and FEV1 (r=0.68, p=0.01). VDP did not demonstrate a significant 
correlation with VO2peak or VO2AT (Figure 2). 
 
Figure 2 shows the relationships between VDP and lung function metrics with VO2peak 
and VO2AT and the correlation metrics are detailed on each plot for all patients. The two 
patients who had a worsening of the distribution of ventilation post exercise (patients’ e 
and f in Figure 1) appear to be outliers in that they had low values for VO2 alongside 
well-preserved VDP and lung function. These two patients had similar levels of aerobic 
fitness to those with more severe lung disease, suggesting that these two patients were 
deconditioned. It is interesting that when these two patients data are removed from 
correlation analysis, the correlations of VO2peak and VO2AT with VDP become highly 
significant (r=-0.78, p=0.006 and r=-0.92, p<0.001 respectively). This observation was 
consistent for LCI (r=-0.76, p=0.01 and r=-0.92, p<0.001 respectively), FEV1  (r=0.81, 




Figure 2: Scatter plots showing the relationships of VO2peak and VO2AT with pre-exercise 
VDP, LCI, FEV1 and RV/TLC. Spearman correlation values are displayed representing analysis 
on all patients. The two patients highlighted by open-circles are the patients with a significant 
worsening in the distribution of ventilation post-CPET. These two patients appear to be outliers 
that have low fitness levels for their given degree of lung disease. The two patients highlighted in 




In this cohort of patients with a broad range of age and lung disease, we have shown that 
by performing a maximal effort CPET, significant quantitative and visual changes in the 
distribution of ventilation were observed post-exercise in most patients. These data 
demonstrate the impact of exercise on lung ventilation.  
 
There is increasing interest in and awareness of the effects of exercise on patients with 
CF(9, 10, 27, 28). Patients with reduced aerobic capacity have a greater risk of morbidity 
and mortality(2-4) and a greater risk of hospitalisation(5). When performing exercise, 
the physiological response is to increase minute ventilation. This increase in ventilation 
on exercise will result in the opening of some airways that were partially obstructed 
during quiet tidal breathing, a phenomenon we have previously demonstrated by 
comparing end tidal inspiration with maximal inspiration on ventilation MRI(16). This 
improvement in ventilation during exercise may allow for improved mucus clearance 
from the airways(7). The data presented here suggests that even by performing a short 
bout of maximal exercise in the form of a CPET, there are significant changes in the 
distribution of ventilation due to the movement of mucus. 
 
These data add to the growing evidence base that exercise can be effective as a method 
of airway clearance. In a previous study, healthy trained subjects showed no change in 
ventilation heterogeneity measured using multi-breath washout following CPET(29). 
For most patients in the current study however (85%), the CPET caused a visible change 
in ventilation. Given the high intra-session repeatability of 129Xe VDP(25), this suggests 
that the changes we observed in VDP and in the distribution of ventilation, relate to the 
underlying CF pathophysiology, and in part are likely a consequence of mucus 
movement in the airways. Change in VDP was greater than the intra-session 
repeatability of VDP, and therefore significant, for 45% of the patients assessed with 
129Xe. For four of these patients and for a further three without a significant change in 
VDP, there was an overall visible improvement in ventilation as was also the case for the 
two patients assessed with 3He.  
 
This illustrates a major advantage of ventilation MRI, namely that it provides detailed 
information as to the location and size of the regions of the lung that have changed. 
Global metrics of lung function, not only FEV1 and LCI but also VDP, measure a minimal 
summary change when there are areas of the lung that change both positively and 
negatively by similar amounts, since the net effect can be close to zero. We have 
demonstrated here that patients without a significant change in VDP or lung physiology 
may still have large positive or negative changes in individual ventilation defects (for 
example patient f, Figure 1). Ventilation MRI can quantify ventilation defects in 3D 
providing regional lung function metrics, which more accurately reflects the regional 
effects of interventions(16).  
 
The observation here that there were visible changes in ventilation for some patients 
without a change in VDP, is in keeping with previous studies where chest physiotherapy 
was performed pre and post 3He ventilation MRI in children with CF(17-19). These 
studies showed that physiotherapy had an effect on the distribution of ventilation, but 
that whole lung VDP was similar post physiotherapy to baseline. In our study, a 
significant change in VDP was observed for some patients, which suggests that maximal 
exercise is performing effectively as a method of chest physiotherapy. 
 
In this study, we observed a mean decrease in LCI post-exercise of 0.4. This is similar to 
the reduction in LCI reported previously post-CPET, where the authors reported a 
reduction in LCI of 0.7(9). It is recommended that all patients with CF perform some 
form of airway clearance as part of their routine management(1), but the evidence for 
one single method over another is limited(30). One reason for this may be that the 
outcome measure utilised is usually the change in FEV1(30). It is now well recognised 
that FEV1 lacks sensitivity to detect small meaningful changes in the lungs and may be a 
reason why exercise trials in CF have not shown statistically significant improvements 
in lung function(10). More sensitive summary measurements of lung function such as 
LCI may be more suitable in those with mild-moderate disease, but only MRI provides 
the detailed regional information across the full spectrum of disease. 
 Patients’ e and f in Figure 1 were the only two patients assessed where there was a 
visible worsening of ventilation post exercise. Patient e had a previous diagnosis of 
asthma, raising the possibility that the worsening in ventilation could be caused by 
exercise induced bronchospasm. There was no corresponding change in this patients 
FEV1, which was within the normal range without evidence of significant airflow 
obstruction, so any bronchospasm that occurred was undetectable by conventional 
means. In these two cases, re-distribution of mucus into larger airways is also a 
plausible explanation. Movement of mucus into more proximal airways would cause 
larger ventilation defects to appear distal to the mucus. In this scenario, despite a 
temporary worsening in overall ventilation, the clinical effect may ultimately be positive 
due to the proximal movement of mucus, which is expectorated at a later time point.  
These two patients however also showed discrepancy between their baseline lung 
function and CPET markers, with low aerobic capacity and relatively well preserved 
lung function. As such, they would be considered deconditioned and regular exercise 
would be recommended to help this. An intriguing possibility also exists: that the short 
term worsening of ventilation heterogeneity is a regular feature of their response to 
exercise, and could be a factor in their deconditioning. Excluding these two outliers from 
correlation analysis, the relationship of VDP with VO2 metrics is significant, supporting 
that in most cases there is a relationship between underlying lung disease and aerobic 
capacity. When all patients were assessed we also found that Ve/VCO2 at peak exercise 
was highly correlated to VDP. This is an intuitive relationship as Ve/VCO2 is a metric of 
ventilation efficiency and higher values for VDP would infer ventilation inefficiency due 
to increased physiological dead-space within the lungs.  
 
The main limitation to this study is the small number of patients involved. However, this 
was an intensive study, with a detailed analysis. Two patients were assessed using 3He, 
but recent work has demonstrated high concordance and minimal bias between 3He and 
129Xe(26, 31) ventilation MRI, and this is unlikely to have affected the main conclusion 
that exercise often changes the distribution of ventilation in patients with CF. We also 
were unable to assess any change in FEV1 with exercise, with only post-exercise 
spirometry performed. Spirometry however was not the primary method for 
comparison and a pre-exercise spirometry would have potentially affected the 
distribution of ventilation as measured on 129Xe MRI and LCI. We were also only able to 
assess the short-term impact of a maximal exercise session performed under clinical 
supervision, and home exercise regimens may not match the intensity. Longer-term 
effects may also differ for exercise and formal chest physiotherapy. These limitations 
could be explored further in longer-term exercise trials, as could the effect of exercise on 




In conclusion, we have shown that maximal exercise has an acute effect on the 
distribution of ventilation in CF, and that increasing VDP is likely associated with 
decreasing exercise capacity. This work demonstrates that maximal exercise has an 
effect on airway clearance and supports recommendations that exercise is beneficial. 
Ventilation MRI is an ideal methodology for assessing the re-distribution of ventilation 
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